The emerging treatment of this peptide represents a exciting breakthrough in the care of the condition. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide239964.ampblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-78970255